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Abstract
Background: There are no accurate data regarding the real prevalence of Chlamydia trachomatis infection in Spain.
Our aim was to determine the prevalence of C. trachomatis infections and the risk factors for acquiring them
among 1,048 young (15–24 years old) inhabitants of Laviana.
Methods: The study was completed in the period between 1st November 2010 and 31st December 2011. We
conducted a capture strategy in the whole population, instead of only in a sample group, with a capture
conducted in schools, in the local health centre, by post and by phone as a last resort. The design was based on
the model used by Shafer to increase screening rates. C. trachomatis was identified by RT-PCR in urine samples.
Results: A total of 487 sexually active people underwent the test, which implies a response rate of 59.8% of the
sexually active people (target population). The prevalence was 4.1% (CI 95%: 3.1-5.8): women: 4% ( CI 95%; 2.8-6.4)
and men: 4.3% (CI 95%: 2.9-7.2). The circulating genotype was the E genotype. There was an increase in the risk of
C. trachomatis infection when barrier contraceptives were not routinely used OR: 4.76 (CI 95%:1.30-17.36) p<0.05.
Conclusions: In our study the prevalence in women resembles those found in other countries in Europe and
the prevalence in men is similar to that in women. Screening for C. trachomatis infection in women would be
cost-effective in Spain given the prevalence of C. trachomatis measured by this study. The use of a condom is the
best preventative measure for avoiding STIs in sexually active people.
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Background
Chlamydia trachomatis is the most frequently reported of
the sexually transmitted infections (STIs) in Europe [1]. C.
trachomatis genital infection can lead to serious sequelae
among women, including pelvic inflammatory disease, tubal
factor infertility, ectopic pregnancy and chronic pelvic
pain [2] and, as other inflammatory STIs, can also
facilitate the transmission of human immunodeficiency
virus infection [3].
The US Preventive Services Task Force (USPSTF) [4]
recommends screening for C. trachomatis infection for
all sexually active non-pregnant young women aged 24
or younger, and older non-pregnant women who are
at increased risk. Although the USPSTF recommenda-
tions are being actively followed in some countries, the
implementation of screening in Spain has not yet been
considered necessary. One of the argued impediments is
the lack of accurate numbers regarding the real prevalence
of C. trachomatis infection in the whole of Spain [5]. We
have sought to determine this prevalence and in doing so,
we were careful to include young males as well, for
whom there is scarce data in the European literature.
Another planned objective was to delineate the risk
factors associated with C. trachomatis positivity for this
target population, information that would be useful for
planning future prevention interventions.
Methods
Demography
The study was conducted in the borough of Laviana,
Asturias, in the north of Spain. It has a population 14,327
distributed in 2 large urban areas and 7 smaller ones. The
traditional economic activities are coal mining, agriculture
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and livestock farming. Education rates are 7.2% university,
51.8% secondary, 26.7% primary and 0.7% illiterate.
Immigration accounts for 0.8% of the population.
Table 1 shows the census information for young people
(15–24 year olds), stratified by age and gender.
Definitions and outcomes measures
Sexual activity was considered as any case of past or
ongoing relationship with the practice of sexual
(vaginal or anal) penetration or any other behavior that
could lead to the transmission of STIs (as fellatio or
cunnilingus). The target population was considered as
the sexually active people among the 1,048 young
(15–24 years old) inhabitants of Laviana and the
prevalence was calculated as the proportion of positive tests
for C. trachomatis among the sexually active individuals
who underwent the test. The survey was completed in the
period between 1st November 2010 and 31st December
2011. Our main outcome measures included the following
variables: individuals who underwent the test, positive
tests for C. trachomatis, sexual activity (self-reported
as yes or no), age (based on the reported date of birth),
gender (female or male), risk factors associated with
C. trachomatis infection (Table 2) and motives for
non-participation in the prevalence determination study.
Sequence of study procedures are illustrated in Figure 1.
Depending on the date when the test was done and the
date of birth, a person could have an age that varied during
the period of the survey. To neutralize this demographic
instability in the calculation of the response rate, we used
the population data that referred to a point halfway through
the study period (31st May 2011). This could produce a
paradoxical effect, such as the capture population being
larger that the population of reference, as happened with
the group of 24 year old females, where captures ascended
to more than 100%.
Ethics
The study was approved by the Regional Committee for
Clinical Research of Principado de Asturias. All the
people testing positive for C. trachomatis infection and
their sex partners were sent to ambulatory care clinics for
treatment and control.
Sexual activity and target population survey
To determine the size of the target population (sexually
active people) of our prevalence study, a questionnaire
on age, gender and sexual activity was carried out on the
young people when they underwent the test, and for the
remaining people who had not undergone the test,
the sexual activity survey was carried out by post. So
finally all young people between 15 and 24 years old living
in Laviana were invited to participate in the study.
Capture strategy
In order to increase the level of participation, this
study was approved by the Health Council and was
publicized within the whole population and in the
media (press, radio). As STI-related testing can create
noticeable barriers, due to fear of stigmatization or
reluctance to share information about sexual activity
and preferences, we employed the method of Shafer
[6] to increase screening rates. In detail, we designed
the following 7 capture strategies. 1) We conducted a
capture strategy in the whole population instead of
only in a sample group. 2) Urine samples were collected
from sexually active people and people who have never been
sexually active. 3) The C. trachomatis test was conducted
on all urine samples in order to eliminate ethical
considerations and increase the number of captured
positives that would have been lost on account of
false declaration by the participants. 4) Informative
workshops were organized in all the secondary
schools in Laviana where the home self-sampling kit
was distributed. 5) Opportunistic capture was also
employed in the local health centre among young
people who attended for other causes. In this setting,
the sexual activity survey was conducted by the resident
physicians and nurses. 6) When all other methods failed,
letters were sent by post to all young 15–24 year olds
that had not been tested. In the case of no reply, the
individuals were contacted by phone as a last resort.
These activities were carried out by the clerical staff
in the Primary Care Center, who were stimulated with
incentives (regular feedback at face-to-face meetings
with the investigating team about their screening rates, days
off and financial incentives) and assertive reinforcement:
“Chlamydia Screening Champions” (the success of this
study depended on their active cooperation). 7) The clerical
staff handed out the home self-sampling kit, and to ensure
confidentiality young people could collect the home
self-sampling kit and return it to various places in the
town, namely pharmacies and the Youth Information
Office, so they could avoid coming to the Health Center
and being recognized by other patients.
Testing kit, RT-PCR and genotype characterization
The home self-sampling kit included: the VERSANT®
system for urine transport, information about how to
collect the urine sample, a questionnaire about their
sexual activity, personal data and an explicit consent
form complete with envelope. The urine samples were
collected and transported with the VERSANT® system.
Then they were sent to the Microbiology Laboratory
Service at the “Hospital Universitario Central de Asturias”,
where they were labeled and identified by barcode, and
refrigerated for 14 to 21 days at +4°C according to the
manufacturer’s guidelines. The automatized real time PCR
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Table 1 Percentage of sexually active young people in the sexual activity survey, estimated target population and response rate stratified by age and gender
Women Men
Sexual activity survey Prevalence survey Sexual activity survey Prevalence survey
Age Census1 RD 2 SA 3 SA% 5 (CI4 95%) Target
population6
RD Response rate % 7 Age Census RD SA SA% (CI
3 95%) Target
population
RD Response rate %
15 44 35 4 11.4 5 3 60 15 44 26 4 15.3 7 4 59
16 42 41 21 51.2 22 12 56 16 50 41 17 41.4 21 12 58
17 42 36 23 63.9 27 21 78 17 44 25 13 52 23 8 35
18 55 30 25 83.3 46 25 55 18 62 27 22 81.4 51 22 44
19 54 30 27 90 49 27 56 19 65 36 32 88.8 58 31 54
20 71 48 47 97.9 70 47 68 20 50 27 26 96.2 48 26 54
21 54 33 31 93.9 51 30 59 21 50 25 23 92 46 23 50
22 51 27 26 96.3 49 26 53 22 56 23 23 100 56 23 41
23 72 44 44 100 72 44 61 23 63 33 33 100 63 33 52
24 34 44 44 100 34 42 124 24 45 29 28 96.5 43 28 64
Age group Age group
15-19 237 172 100 58.1 138 88 63.9 15-19 265 155 88 56.7 150 77 51.2
(50.4-65.8) (48.6-64.8)
20-24 282 196 192 97.9 276 189 68.4 20-24 264 137 133 97 256 133 51.9
(94.8-99.4) (92.6-99.1)
15-24 519 368 292 79.3 412 277 67.2 15-24 529 292 221 75.7 400 210 52.4
(75.1-83.6) ( 70.6-80.8)
Women and Men
Sexual activity survey Prevalence survey
Age group Census RD SA SA% (CI 95%) Target population RD Response rate %
15-24 1048 660 513 77.7 815 487 59.8
(74.7-80.9)
1 Census: population data that referred to a point halfway through the study period (31st May 2011); 2 RD: Responders; 3 SA: Sexually active; 4 CI: confidence interval; 5 SA%: Rate of sexually active youth in the Sexual



















(kPCR, Versant CT/GC DNA 1.0, Siemens Healthcare
Diagnostics) uses single tube detection for C. trachomatis
and Neisseria gonorrhoeae and internal control. For geno-
type characterization, a fragment of the ompA gene was
amplified according to the report by Lysen [7]. In detail,
amplicons were purified by using a Montage DNA Gel
Extraction Kit (Millipore, Bedford, MA, USA) and
sequenced with the BigDye Terminator Cycle Sequencing
Kit (Applied Biosystems, Foster City, CA, USA). The
individual sequences were aligned using the Clustall-W2
program (European Bioinformatics Institute).
Risk factors survey
Those who answered positively to active sexual activity
and underwent the urine test filled out a form about risk
factors for C. trachomatis positivity. The survey was
carried out in a Health Centre on the subjects who
gave a positive result for C. trachomatis in the test,
and by an anonymous questionnaire on the subjects
who gave a negative result.
Assessment of the prevalence survey’s quality
In order to account for assignment bias an additional
survey was carried out at the end of the prevalence study
for non-responders. This survey looked into the motives
for non-participation in the prevalence study, it was
anonymous and carried out in secondary schools during
sex education workshops in the case of young people
aged 15–17 years old and by post for subjects between
18 and 24 years old.
Statistical analysis
We calculated the prevalence in sexually active
people using the Wilson score to estimate the confi-
dence interval (95%). We chose the Wilson score due
to its design for lower prevalence studies. For the risk
factor survey, the STATCAL program (EPIINFO v7, CDC,
Atlanta, USA) was used for bivariate over multivariate
analysis. For binary and multinomial logistic regression,
and analysis of the sensitivity of assumed models we used
SPSSv15 software (SPSS Inc, Chicago, IL, USA) together
with an analysis of the sensitivity of different models. Esti-
mation of punctual association magnitude was performed
with the Odds ratio from the exp (B) of the model to
interval estimation with the OR confidence interval.
Results
Sexual activity and target population survey
Six hundred and sixty young people (63%) among 1048
young inhabitants of Laviana answered questions about
their sexual activity and gender. Out of these 660 young
people, 513 were sexually active (77.7%), which implies an
estimated sexually active target population of 815 young
15–24 year olds (Figure 2).
In Table 1, the percentage of sexually active young
people in the sexual activity survey, the estimated target
population, the people who underwent the test and





P Value OR (CI 95 %)
Habitual use of condom
No 17 50 0.018 4.76 (1.30-17.36)
Yes 3 42
Age in years
15-17 2 20 0.25 2.47 (0.53-11.53)
18-24 8 73
Last sexual relation with condom
No 12 35 0.07 2.44 (0.91-6.57)
Yes 8 57
Age group
15-19 5 40 0.14 2.26 (0.76-6.75)
20-24 15 53
Sexual orientation
Heterosexual 20 92 1 NA1
Homo/bisexual 0 1
New sexual partner in last 3 months
0-1 14 69 0.64 1.29 (0.44-3.75)
>1 6 23
Early oral contraceptive use
No 13 63 0.54 0.70 (0.23-2.17)
Yes 7 30
History of abortion
No 20 89 0.99 NA
Yes 0 4
Travel abroad
No 14 63 0.84 0.9 (0.31-2.57)
Yes 6 30
Drug use
No 20 87 0.99 NA
Yes 0 6
Alcohol use
No 9 30 0.28 0.58 (0.22-1.55)
Yes 11 63
Tobacco use
No 16 73 0.88 0.91(0.27-3.03)
Yes 4 20
History of urogenital disorders
No 15 71 0.83 1.12 (0.37-3.46)
Yes 5 21
1 NA: Not Applicable.
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the response rate of the prevalence survey are shown
stratified by age and gender.
The prevalence survey included 487 people with sexual
activity, which implies a response rate of 59.8% of the
target population. The distribution by age group and
gender of the response rate was: a) Women aged 15–24
years 67.2% (15–19 years 63.8% and 20–24 years 68.4%);
b) Men aged 15–24 years 52.4% (15–19 years 51.2% and
20–24 years 51.9%).
Prevalence survey
The survey to determine the prevalence of C. trachomatis
infection in the community included 581 people aged
15–24 years, of whom 487 were sexually active and
94 have never been sexually active. Among the 487
sexually active people, twenty urine samples were
found to be positive. All samples from the population
without sexual activity were negative. In Figure 2, the
whole testing algorithm for the prevalence survey is
depicted graphically. The overall prevalence was 4.1%
(CI 95%: 3.1-5.8): women 4% (CI 95%: 2.8-6.4) and
men 4.3% (CI 95%: 2.9-7.2). The distribution by age
groups and gender was: a) Women, aged 15–19 years 2.3%
(CI 95%: 1.2-7.2) and 20–24 years 4.8% (CI 95%: 3.3-8.0).
b) Men aged 15–19 years 3.9% (CI 95%: 2.3-9.9) and
20–24 years 4.5% (CI 95%: 2.9-8.6).
The phylogenetic analysis of C. trachomatis from 17
positive samples (85% of the positive urine samples)
showed that the genotype circulating in this population
was E (100%).
Motives for non-participation in the prevalence
determination survey
One hundred and ten of the 328 sexually active people
who had not undergone the test declared their reasons
for not participating in the prevalence study. 38.1% were
unaware of the existence of the investigation, 28.6% did
not see their participation as necessary as they did not
Figure 1 Sequence of study procedures.
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have “risky” sexual relations, 7.2% said they were not
interested in taking the test, 6.8% said they forgot they
had an appointment with the doctor, 6.7% said they were
on holiday when it was their turn to do the test, 4.8%
did not agree with the nature of the study, 3.1% did not
participate due to concern that they might test positive
and have to communicate this to their partner, 3.1%
considered STIs to be “a myth” and 1.6% did not trust
the confidentiality of the test.
Risk factors for C. trachomatis positivity
Ninety three sexually active 15 to 24-year-olds with
negative urine test and 20 with positive urine test
completed the questionnaire on the predisposing risk
factors for C. trachomatis positivity (Table 2).
The risk factor of routine sexual activity without
the use of condoms showed a statistically significant
association with C. trachomatis infection: OR: 4.76
(CI 95%:1.30-17.36) p<0.05. There was no statistically
significant association with other variables.
Discussion
Because of the large burden of disease and risks associated
with infection, the USPSTF recommends screening for C.
trachomatis infection for all sexually active non-pregnant
young women aged 24 or younger and older non-pregnant
women who are at increased risk [4]. The threshold popu-
lation prevalence of C. trachomatis infection over which
the evaluations were cost-effective varied from 3.1 to 10%.
Screening can be cost-effective at a prevalence as low as
1.1%, when age is used to select women and nucleic
acid amplification based tests are carried out on urine
samples, although the large numbers of unnecessary
tests diminishes effectiveness [8].
There are scarce data regarding the prevalence of C.
trachomatis infection in Spain, all of them from risk
population attending in STI clinics. Corbeto et al. studied
people under 35 years-old attending in sexual health clinic
and concluded that overall C. trachomatis prevalence
was 4% , but it was higher in those under 25 years-old
(5.8%) and higher than in our non-selected population
(4.1%) [9]. Nogales et al. studied young and adults
attending in a clinic for STI, 50% of them belonged
to groups engaged in high risk sexual practices as
commercial sex workers, MSM, users of prostitution,
and the prevalence was 6% (4.3% in women and 7.8%
in men) [10]. Similar prevalence (5.9%) was found by
Folch et al. in immigrant female sex workers, but these
data cannot be compared with our study due to differences
in population characteristics [11].
Figure 2 Prevalence survey results: distribution per age and gender.
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Comparisons with prevalence data previously reported
by other countries are not simple, owing to the use of
different age groups to calculate rates. In our survey, the
C. trachomatis prevalence in women (4%) resembles
those found in other countries in Europe. In a sexual
survey in France in 2006 [12], the prevalence of C.
trachomatis in the national population in women in the
18–24 year group was 3.6% (CI 95%: 1.9-6.8) and in men
2.4% (CI 95%: 1–5.7). In the UK, in the second National
Survey of Sexual Attitudes and Lifestyles [13] the prevalence
of C. trachomatis in women in the 18–24 years group was
3% (CI 95%: 1.7-5) and in men 2.7% (CI 95%: 1.2-5.8). In
Slovenia, considering the prevalence in the captured general
population (1999–2011), the prevalence in women
and men in the 18–24 years group was found to be
4.7% (CI 95%: 2.5-8.5), and was the same in both
genders [14]. Confidence intervals for these prevalence
estimates were wide, with overlapping 95% confidence
intervals, and the differences between countries were
not statistically significant.
In the USA, where substantial racial/ethnic disparities in
C. trachomatis infection exist, the prevalence in women is
higher for 15–19 year olds and lower for 20–24 year olds
when compared to the results in our survey. According to
data from the National Health and Nutrition Examination
Survey 1999–2008 (NHANES) [15], the C. trachomatis
prevalence among sexually active women in the 14–19 age
range was 6.8% (4.4% among non-Hispanic Caucasians
and 16.2% among non-Hispanic Afro-Americans) and
in the 20–24 age range it was 3.2% (1.3% among non-
Hispanic Caucasians and 12.1% among non-Hispanic
Afro-Americans). In our study the prevalence of C.
trachomatis in the 20–24 years group (women 4.8% and
men 4.5%) is higher than that seen in the 15–19 years
group (women 2.3% and men 3.9%). In the 15–19 years
group the level of sexual activity was especially low
(women 58.1% and men 56.7%) and in the 20–24 years
group it was women 97.9% and men 97% (Table 1). The
prevalence of C. trachomatis infections among young
adults (aged 18–26 years) in the USA who participated in
the nationally representative National Longitudinal Study
of Adolescent Health during 2001–2002, was: global
prevalence 4.19%; women (4.74%) and men (3.67%) [16].
Our prevalence in men (4.3%) was similar to that in
women (4%). Increasing efforts in partner notification
and their treatment may contribute at least as much to
the control of C. trachomatis infection as increasing
screening coverage rates [17].
Our results, in both men and women, suggest that
prevention of C. trachomatis with routine condom use
could lead to a reduction in the observed C. trachomatis
infection rates. However, as non-compliance with safe
sex practices is commonly seen in young age groups and
complications of a C. trachomatis infection are sometimes
severe, with infertility and major sequels, universal free
screening for young sexually active people in the
health sector would aid the immediate recognition of the
infection and thus facilitate action towards implementing
the available effective therapy.
A response rate of 60% has been used as the threshold
of acceptability by some and is valid as a measure of
survey quality; however 60% is only a “rule of thumb”
that masks a more complex issue. Non-response bias is
more useful for understanding survey limitations [18].
This non-response can potentially bias the prevalence
estimates under 2 conditions: if the response rate varies
according to an observed attribute, such as age, race,
gender or sex, which is associated with prevalence or if
the non-respondents have a different pattern of prevalence
from respondents with similar observed attributes [13].
But once the variable of age was adjusted according to
sexual activity by means of a stratified analysis, it showed
us that there was no significant difference with regards
to participation related to age (Table 1). All this,
being considered with the analysis of the motives for
non-participation, with a response rate of 59.8% in
our prevalence determination study, showed us that the
distribution of the captured population was not distorted
and comparable to the total reference population.
There are some limitations in our survey. Only 93
of the 467 sexually active young people with a nega-
tive urine test answered the survey on risk factors for
C. trachomatis infection. Due to the fact that the
young people had to give their names in the preva-
lence survey, we were worried that the numbers par-
ticipating in that prevalence survey could have been
reduced, as the young people would not want to be
identified on account of their reluctance to report
their sexual activity and preferences. Therefore, we
made the second test, the sexual risk factor survey,
anonymous and at a later date. This second survey
had low numbers of participants showing the young
people’s reluctance to report their sexual activity and
preferences. Another limitation is the target population
(the sexually active population), an unknown quantity,
was determined by an initial survey, and therefore it must
be considered as an estimation. Other limitations are
the potentially inaccurate reporting of sexual behaviour
data (social desirability bias), response rate and lack
of information about non-responders, and lack of
generalisability of these results.
The generalization of these prevalence values to other
places in Spain could be possible but considerations about
sample size, geographical limitations, lack of socioeconomic
stratification and other factors, should be considered. We
think that this is the first study in Spain to determine the
communitary prevalence of C. trachomatis genital infection
in young people.
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Conclusions
The prevalence in our survey resembles those found in
other countries in Europe. Screening for C. trachomatis
infection in women would be cost-effective in Spain
given the prevalence of C. trachomatis measured by this
study. The use of a condom is the best prevention measure
for avoiding STI in sexually active people.
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